These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 29642484)
21. Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates. Roy LO; Lemelin M; Blanchette M; Poirier MB; Aldakhil S; Fortin D J Neurooncol; 2022 Dec; 160(3):601-609. PubMed ID: 36342588 [TBL] [Abstract][Full Text] [Related]
22. Chemokine receptor CXCR7 is an independent prognostic biomarker in glioblastoma. Deng L; Zheng W; Dong X; Liu J; Zhu C; Lu D; Zhang J; Song L; Wang Y; Deng D Cancer Biomark; 2017 Jul; 20(1):1-6. PubMed ID: 28759950 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis. Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288 [TBL] [Abstract][Full Text] [Related]
24. Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma. Johansson E; Zhai Q; Zeng ZJ; Yoshida T; Funa K Exp Cell Res; 2016 May; 343(2):118-125. PubMed ID: 27048878 [TBL] [Abstract][Full Text] [Related]
25. Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta. Roy LO; Poirier MB; Fortin D Invest New Drugs; 2015 Oct; 33(5):1020-31. PubMed ID: 26271735 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of STAT3 gene expression in patients with glioblastoma tumors: a study from Western India. Trivedi T; Panchal K; Bhalala N; Trivedi P J Egypt Natl Canc Inst; 2022 Jul; 34(1):30. PubMed ID: 35844028 [TBL] [Abstract][Full Text] [Related]
28. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma. Zhang W; Sun Y; Liu L; Li Z Med Sci Monit; 2017 Sep; 23():4506-4512. PubMed ID: 28926524 [TBL] [Abstract][Full Text] [Related]
31. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma. Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134 [TBL] [Abstract][Full Text] [Related]
32. The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study. Sferra R; Pompili S; Festuccia C; Marampon F; Gravina GL; Ventura L; Di Cesare E; Cicchinelli S; Gaudio E; Vetuschi A Eur J Histochem; 2017 May; 61(2):2732. PubMed ID: 28735518 [TBL] [Abstract][Full Text] [Related]
34. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma. Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746 [TBL] [Abstract][Full Text] [Related]
35. TGF-β links glycolysis and immunosuppression in glioblastoma. Gong L; Ji L; Xu D; Wang J; Zou J Histol Histopathol; 2021 Nov; 36(11):1111-1124. PubMed ID: 34323284 [TBL] [Abstract][Full Text] [Related]
37. SEMA6A is a prognostic biomarker in glioblastoma. Zhao J; Tang H; Zhao H; Che W; Zhang L; Liang P Tumour Biol; 2015 Nov; 36(11):8333-40. PubMed ID: 26014517 [TBL] [Abstract][Full Text] [Related]
38. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998 [TBL] [Abstract][Full Text] [Related]
39. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
40. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients. Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]